Orphazyme
Orphazyme: Eyeing a Secondary Listing in the US (Redeye)

2020-07-01 13:32
Earlier today, we learned that Orphazyme had submitted a draft registration statement for a potential public offering in the United States. Orphazyme’s shares will continue to trade on Nasdaq Copenhagen. Naturally, we welcome this news. By allowing its shares to trade in the US, the company will increase its access to US investors. We also believe this could have a positive effect on the company’s valuation. We look forward to learning about this progress continuously during the second half of 2020.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Orphazyme - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -